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The degree of proteinuria during preeclampsia has been
considered to be a marker of severity of the disease and of
endothelial dysfunction. The aim of the study was to assess
whether the degree of proteinuria in preeclamptic pregnancy
is related to impairment of vascular dilatation and/or kidney
function years after the index pregnancy. Thirty women with
a history of severe preeclampsia divided into low (n¼ 8, dU-
prot o5 g/day) and high (n¼ 22, dU-prot X5 g/day)
proteinuric groups and 21 women with previous
normotensive pregnancy were studied 5–6 years after index
pregnancy. Renal function and blood pressure were assessed
together with venous occlusion plethysmography, where
changes in brachial artery blood flow, induced by intra-
arterial infusions of an endothelium-independent (sodium
nitroprusside) and an endothelium-dependent
(acetylcholine) vasodilator, were measured. The results
showed similar renal function in all groups. There was no
difference in vasodilation between preeclamptic groups and
controls or correlation between degree of proteinuria during
index pregnancy and present vasodilation. We conclude that
the degree of proteinuria during preeclampsia does not
predict vascular dilatation or renal function 5–6 years after
preeclamptic pregnancy.
Kidney International (2006) 70, 1818–1822. doi:10.1038/sj.ki.5001902;
published online 27 September 2006
KEYWORDS: preeclampsia; proteinuria; vascular dilatation
Preeclampsia is characterized by high vascular resistance,
diminished vascular volume, decreased arterial compliance,
and endothelial dysfunction.1–3 Preeclamptic proteinuria is
particularly connected to endothelial dysfunction and the
degree of proteinuria is regarded as a marker of the severity of
the disease.4–8 In most cases, elevated blood pressure and
proteinuria disappear within a few weeks postpartum;7
patients with persisting proteinuria are more likely to have
underlying renal disease.9 However, microalbuminuria with
otherwise normal renal function has been found in women
several years after preeclamptic pregnancy suggesting persist-
ing endothelial injury.10,11 Recent studies showing impaired
vascular dilatation in women several years after preeclamptic
pregnancy support this hypothesis.12–15 In the kidney, the
preeclamptic insult results in decrease in renal blood flow and
glomerular filtration rate4,16 and proteinuria, which is
considered to reflect the extent and severity of glomerular
damage.17 According to the results of recent studies,
structural and charge- and size-selectivity changes in the
glomerular filtration barrier appear to account, at least in
part, for the development of proteinuria.4,18,19 A history of
preeclampsia has been associated with an increased risk of
coronary artery disease (CAD) in women.20–24 According to
Irgens et al.,25 women with preeclampsia who deliver preterm
are at an even greater risk of CAD; these women are most
often also those who have more considerable proteinuria26
compared with those delivering at term. Furthermore, we
know from studies on non-obstetric patients that nephrotic
syndrome is associated with a several-fold increased risk of
CAD,27 and endothelial dysfunction.28
In the light of above, the aim of the present study was to
investigate, if the degree of proteinuria during preeclamptic
pregnancy has an influence on kidney function and vascular
dilatation 5–6 years after the index pregnancy.
RESULTS
During pregnancy there was no difference in age or body
mass index between the low and high proteinuric groups or
the controls (Table 1). This was also true at the time of the
follow-up (Table 2). Hypertension and proteinuria appeared
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earlier in the high proteinuric group than in the low
proteinuric group, they delivered earlier and had infants
with lower birth weight, but statistically this difference was
insignificant. Systolic and mean arterial pressure in the high
proteinuric group differed significantly compared with the
controls (P¼ 0.03 and 0.048, respectively). There was no
difference in kidney function between the three groups
(Table 2). Microalbuminuria (430 mg/24 h) was found in
two women in high proteinuric group, but the difference was
not significant (P¼ 0.64). The increase in vasodilation was
dose-dependent and similar in each group. Increase in
vasodilation (%) in response to sodium nitroprusside
(SNP) 3 mg/min was 340 (267–368) in the group o5 g, 270
(190–336) in the group X5 g, and 397 (325–451) in the
controls (P¼ 0.009), to SNP 10 mg/min 522 (494–540) in the
group o5 g, 338 (276–729) in the group X5 g, and 581
(386–687) in the controls (P¼ 0.148). Endothelium-depen-
dent response to acetylcholine (ACh) 7.5 mg/min was 447
(189–672) in the group o5 g, 313 (219–377) in the group
X5 g, and 443 (340–575) in the controls (P¼ 0.09) and to
ACh 15 mg/min 462 (261–851) in the group o5 g, 365
(233–508) in the group X5 g, and 547 (424–678) in the
controls (P¼ 0.6); there were no significant differences
between the three groups in post hoc test. Additionally, there
was no correlation between the degree of proteinuria during
preeclampsia and the present endothelium-independent or
endothelium-dependent vasodilation (Figure 1a and b,
respectively). In the group of recurrent preeclampsia
(N¼ 3), the vasodilation was impaired by 10–26% in
endothelium-independent vasodilation (P¼NS) and in
endothelium-dependent vasodilation by 24–26% (P¼NS)
compared to women with a single preeclampsia episode (data
not shown).
DISCUSSION
The present study demonstrates that women even with
substantial proteinuria during preeclampsia 5–6 years pre-
viously have similar vascular function as women with a low
Table 1 | Demographic data during pregnancy
Patients (dU-prot o5 g) (n=8) Patients (dU-prot 45 g) (n=22) Controls (n=21) Overall ANOVA P
Pregnancy
Age (years) 3177 3375 3074 0.09
Body mass index (kg/m2, o10 gw) 2573 2474 2472 0.4
Maximum proteinuria in pregnancy (g/day) 1.49 (1.1–3.1) 12.03 (6.0–16.5) NA
Systolic BP maximum (mmHg) 177714* 174719* 121710 o0.001
Diastolic BP maximum (mmHg) 10978* 11078* 7277 o0.001
Constant proteinuria, dU-prot40.3 g (gw) 3374 3174 NA 0.1
Blood pressure constantly 4140/90 (gw) 3373 3174 NA 0.1
S-Urate (mmol/L) 421765 395784 NA 0.5
Delivery
Gestational weeks at delivery 34 (33–38)* 32 (29–36)* 40(40–41) o0.001
Birthweight (g) 1973 (1545–2613)* 1567 (975–2318)* 3615 (3277–3760) o0.001
ANOVA, analysis of variance; BP, blood pressure; gw, gestational weeks; NA, non-applicable.
Values are expressed as mean7s.d. or median and interquartile (percentiles 25–75) range. Values of Po0.05 are considered significant.
*Po0.001 versus controls.
Table 2 | Demographic and kidney function data 5–6 years after preeclampsia
Patients (dU-prot o 5 g) (n=8) Patients (dU-prot X5 g) (n=22) Controls (n=21) Overall ANOVA P
Age (years) 3777 3875 3674 0.4
Body mass index (kg/m2) 2775 2573 2474 0.3
Blood pressure systolic (mmHg) 124 (115–139) 123 (113–136)* 112 (102–123) 0.03
Blood pressure diastolic (mmHg) 8478 82713 7577 0.04
Mean arterial pressure (mmHg) 95 (92–108) 93 (86–103)* 89 (81–95) 0.048
Smoking 41/day (%) 1/8 (13%) 4/22 (18%) 7/21 (30%) 0.4
Urine volume/24 h (ml) 1675 (1075–2350) 1625 (1100–2275) 1750 (1000–2400) 0.9
dU-alb-Mi (mg/day) 5.5 (4–10) 7 (6–13) 6 (4.5–9) 0.3
U-alb (mg/L) 3.5 (3.4–5) 7.4 (3–6.3) 4 (3–5) 0.8
S-Urate (mmol/l) 283757 245764 240749 0.2
U-Crea (mmol/l) 7.072.4 7.673.5 7.573.4 0.9
Crea-cl (ml/s/1.73 m2) 1.8 (1.3–2.1) 2.1 (2.0–2.2) 2.1 (2.0–2.5) 0.08
fB-gluc (mmol/l) 4.3 (3.9–4.7) 4.4 (4.2–4.8) 4.4 (4.2–4.6) 0.7
ANOVA, analysis of variance.
Data are presented as mean7s.d. or median and interquartile (percentiles 25–75) range. Values of Po0.05 are considered significant.
*Po0.05 versus control group.
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degree of proteinuria and controls measured with venous
occlusion plethysmography and intra-arterial vasodilators.
We found no impairment in renal function between the
groups.
The association between the degree of proteinuria during
preeclampsia and postpartum endothelium-dependent and -
independent vasodilation has not to our knowledge been
studied previously and vascular studies during preeclampsia
have not included correlations to the degree of proteinuria.
Preeclampsia is considered severe if proteinuria exceeds
5 g/day8 and it has been shown that a high degree of
proteinuria is associated with earlier onset of the disease and
delivery and a higher rate of prematurity problems.26
Proteinuria was pregnancy-related, as even proteinuria up
to 33 g (per 24 h) disappeared postpartum and renal function
totally recovered. Renal function test results were normal in
the studied women, which is consistent with the results of
previous studies where the degree of preeclamptic proteinuria
has been low to moderate29,10,11 and even massive.7
Microalbuminuria is considered to be a marker of
generalized vascular dysfunction30 and is an independent
risk factor of cardiovascular disease.31–33 Two follow-up
studies have shown an increased incidence of microalbumi-
nuria (14–42%) in women with previous preeclampsia years
after the index pregnancy.10,11 In our study, there was no
difference between the groups in the incidence of micro-
albuminuria 5–6 years after the index pregnancy. The
difference between these study results could be explained
by the higher incidence of chronic hypertension; 20% in the
study by Nisell et al.10 in their preeclampsia group compared
with our 2/30 (7%).
Five to six years after preeclamptic pregnancy, there were
no significant differences in vasodilatory capacity between the
low and high proteinuric groups. Hence, even if the degree of
glomerular impairment as defined by proteinuria during
preeclampsia was extensive in several of the women, it does
not seem to predict poorer endothelial vasodilatory function
in later life; the endothelium appears to recover equally after
high or low proteinuric disease. Another feature closely
related to endothelial function is blood pressure. In this
regard, our preeclamptic study groups did not differ
significantly from each other during preeclampsia. After 5–6
years, blood pressure was higher in the high proteinuric
group than in the controls. Hence, we cannot rule out the
possibility that women in the high proteinuric group may
develop endothelial dysfunction more easily later in life in
parallel with increase in blood pressure, as previous studies
have shown preterm-delivering preeclamptic women to be at
an especially high risk for later CAD.20–23 Interestingly,
women with recurrent preeclampsia have been shown to have
even more limited vasodilatory capacity (12). As a sign of a
more compromised status in the vasculature, it may also
illustrate a higher risk for later CAD. Our study showed
decrease in both endothelium-independent and endothe-
lium-dependent vasodilation in the group of recurrent
preeclampsia, although the number of patients was too small
to draw any conclusions. In addition, to accurately study a
group of patients with recurrent preeclampsia, the study
cannot include women in fertile age as the future pregnancy
number and outcome is not known. Limitations of our study
are the relatively small numbers of patients and controls and
the fact that we were not able to study their vascular function
during pregnancy. On the other hand, in this study we have
used an accurate and invasive method to study vascular
dilatation and it involves one of the largest study populations
(relatively young women) in whom this laborious method
has been used.
In conclusion, the degree of preeclamptic proteinuria does
not seem to have a predictive value to vasodilatory capacity
or renal function 5–6 years after preeclamptic pregnancy.
MATERIALS AND METHODS
Pregnancy data was collected from the hospital records of women
treated for preeclampsia (IC-10 diagnosis O14.1) at Helsinki
University Central Hospital during the period 1996–1998. Only
women with a well-documented 24-h urinary output of protein
(dU-prot) were included. Subjects with concomitant disease such as
chronic hypertension, kidney disease, coagulation disorders, dia-
betes, or a history of gestational diabetes were excluded. Of the 83
eligible subjects, 21 refused to participate and 32 were not reached.
The study group thus consisted of 30 women, divided into two
groups according to maximal total diurnal proteinuria, that is, ‘low’
o5 g/day (median dU-prot 1.5 g, range 0.75–4.97 g/day) and ‘high’
X5 g/day (median dU-prot 12.0 g, range 5.1–33.44 g/day) protei-
nuria groups. The control group (n¼ 21) consisted of subjects
selected at random from women with a record of normal,
   
0
600






























Figure 1 | Correlation between proteinuria and forearm blood
flow. (a) Correlation between proteinuria during index pregnancy
and increase in forearm blood flow in percentage (%) in response to
endothelium-independent vasodilator SNP. Values of Po0.05 are
considered significant. (b) Correlation between proteinuria during
index pregnancy and increase in forearm blood flow in percentage
(%) in response to endothelium-dependent vasodilator ACh. Values
of Po0.05 are considered significant.
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uncomplicated pregnancy during the same time period. All women
were examined 5–6 years after the index pregnancy. Two women
with hypertension, diagnosed after preeclamptic pregnancy, with-
held their antihypertensive medication for three days before the
study. None of the women were on estrogen substitution. Non-
steroidal anti-inflammatory drugs and other drugs affecting
endothelial function were withheld for 7 days before the study.
The Ethics Committee of Helsinki University Central Hospital
approved the experimental protocol and every woman gave her
written consent of participation to the study.
Endothelial function was assessed in vivo by measurement of
forearm arterial blood flow by venous occlusion plethysmography
during intra-arterial vasodilator infusion.34–36 Measurements were
performed in a quiet, temperature-controlled (20–211C) room in the
morning after an overnight fast (minimum 12 h). The endothelium-
independent vasodilator SNP and the endothelium-dependent
vasodilator ACh were infused into the brachial artery in the
following sequence: SNP at 3 and 10 mg/min for 6 min each, ACh at
7.5 and 15 mg/min in the same way. Saline was infused before and
between the two vasodilators to allow the flow to return to the basal
level before the next infusion. Forearm blood flow was measured
during the last 3 min of every 6-min infusion period and the mean
of the last five recordings was used in the analysis. Blood pressure
was measured after a 30-min rest in a supine position with a
calibrated oscillometric manometer (OMRON M4, HEM-722C1-E)
by a trained midwife. One of three cuff sizes (small, medium, large)
was used according to the manufacturer’s guidelines. Blood samples
for assay of uric acid and blood glucose were taken and 24-h urine
sampling was started. The collected urine was analyzed next day
with simultaneous analysis of 24 h albumin excretion (immuno-
turbidimetric ‘in-house’ analysis [SFS-EN ISO/IEC 17025]), and
both urine and serum creatinine (enzymatic colorimetric, accredited
method [SFS-EN ISO/IEC 17025]).
Statistics
Normally distributed data is given as mean7s.d., whereas non-
normally distributed data is given as median with interquartile range
(25th and 75th percentiles). Student’s t-test was used for normally
distributed data and the Mann–Whitney U test for non-normally
distributed data in the two groups when no pregnancy data on the
controls was available. For comparisons between the controls and
the two patient groups, one-way analysis of variance was performed,
followed by the Bonferroni post hoc test for normally distributed
data. Kruskal–Wallis analysis of variance by ranks was used for non-
normally distributed data. Frequencies of categorical data in the
three groups were compared by means of Fisher’s exact test. The
correlation between proteinuria during index pregnancy and flow
change (%) in response to vasodilators was calculated with
Spearman rank correlation coefficient (rs). Calculations were
performed with NCSS 2000 software (Number Cruncher Statistical
Systems, Kaysville, UT, USA). The power to detect a 1.5-fold
difference in vasodilation at a P level of 0.05 was 80%. A P-value
o0.05 was considered statistically significant.
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